Skip to main content

Lyrica CR News

2015 to 2021 Saw Increase in Gabapentinoid Use

TUESDAY, Jan. 23, 2024 – Use of gabapentinoids has increased since 2015, particularly for chronic pain, according to a study published in the January/February issue of the Annals of Family Medicine. ...

Gabapentinoids Linked to Increased Risk for Severe Exacerbation in COPD

TUESDAY, Jan. 16, 2024 – Gabapentinoid use is associated with an increased risk for severe exacerbation among patients with chronic obstructive pulmonary disease (COPD), according to a study...

Hate Driving Your Cat to the Vet? FDA Just Approved a Drug for That

TUESDAY, Nov. 21, 2023 – If you belong to one of the 46 million American households with a cat, you already know how stressful a trip to the vet can be for your feline – and you. Rescue might be on...

FDA Medwatch Alert: FDA Warns About Serious Breathing Problems with Seizure and Nerve Pain Medicines Gabapentin (Neurontin, Gralise, Horizant) and Pregabalin (Lyrica, Lyrica CR) in Patients with Respiratory Risk Factors

December 19, 2019 – The U.S. Food and Drug Administration (FDA) is warning that serious breathing difficulties may occur in patients using gabapentin (Neurontin, Gralise, Horizant) or pregabalin...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Neuropathic Pain, Diabetic Neuropathy, Diabetic Nerve Damage, Persisting Pain, Shingles, Postherpetic Neuralgia

Lyrica CR patient information at Drugs.com